Oncological outcomes and safety after spinal reirradiation with stereotactic body radiotherapy
SBRT reirradiation for progressive or recurrent spinal metastases appears to be a safe and effective treatment option, offering durable local control and pain relief with low toxicity. Future prospective and multi-institutional studies are warranted to validate these findings.
Authors
- Daniel Lubelski (ORCID: https://orcid.org/0000-0002-9403-9509)
- Palak P Patel (ORCID: https://orcid.org/0000-0002-0586-3708)
- Kristin J. Redmond (ORCID: https://orcid.org/0000-0003-3442-4613)
- Debraj Mukherjee (ORCID: https://orcid.org/0000-0002-5403-8237)
- Lawrence Richard Kleinberg (ORCID: https://orcid.org/0000-0003-2473-2305)
- Binbin Wu (ORCID: https://orcid.org/0000-0001-7953-0992)
- Nicholas Theodore (ORCID: https://orcid.org/0000-0001-5355-2683)
- M.C. LeCompte (ORCID: https://orcid.org/0000-0002-3116-007X)
- Ali Bydon (ORCID: https://orcid.org/0000-0002-3058-1470)
- Khaled M. Kebaish (ORCID: https://orcid.org/0000-0002-1235-6202)
- Neil K Vuppala
- Sang Hun Lee (ORCID: https://orcid.org/0000-0001-5942-8309)
- A Damiano
Institutions
- Johns Hopkins University (US)
- Alabama College of Osteopathic Medicine (US)
- Johns Hopkins Medicine (US)
- Radiation Oncology Associates (US)
Publication Details
- Journal
- Journal of Neurosurgery Spine
- Published
- 2025-09-12
- DOI
- https://doi.org/10.3171/2025.4.spine241281
- Citations
- 2
- Primary Topic
- Management of metastatic bone disease
- Type
- article
- Field-Weighted Citation Impact
- 4.01